ALDR
Baird Financial Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-54,615
| Closed | -$560K | – | 1349 |
|
|
2018
Q4 | $560K | Buy |
54,615
+3,840
| +8% | +$39.4K | ﹤0.01% | 953 |
|
|
2018
Q3 | $755K | Buy |
50,775
+1,021
| +2% | +$15.2K | ﹤0.01% | 925 |
|
|
2018
Q2 | $786K | Buy |
49,754
+403
| +0.8% | +$6.37K | 0.01% | 885 |
|
|
2018
Q1 | $627K | Sell |
49,351
-9,989
| -17% | -$127K | ﹤0.01% | 950 |
|
|
2017
Q4 | $679K | Sell |
59,340
-12,592
| -18% | -$144K | ﹤0.01% | 925 |
|
|
2017
Q3 | $881K | Buy |
71,932
+43,996
| +157% | +$539K | 0.01% | 834 |
|
|
2017
Q2 | $320K | Buy |
27,936
+9,495
| +51% | +$109K | ﹤0.01% | 1070 |
|
|
2017
Q1 | $384K | Buy |
18,441
+1,349
| +8% | +$28.1K | ﹤0.01% | 1016 |
|
|
2016
Q4 | $356K | Buy |
17,092
+1,841
| +12% | +$38.3K | ﹤0.01% | 1013 |
|
|
2016
Q3 | $500K | Sell |
15,251
-479
| -3% | -$15.7K | ﹤0.01% | 937 |
|
|
2016
Q2 | $402K | Buy |
+15,730
| New | +$402K | ﹤0.01% | 969 |
|